XML 13 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Ordinary Shares
Additional Paid-in Capital
Other Undenominated Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Redeemable Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2019   53,622,206          
Beginning balance at Dec. 31, 2019 $ 1,618,055 $ 4,635 $ 577,961 $ 1,052 $ (75,819) $ 1,110,226  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 91,696         91,696  
Exercise of share options (in shares)   31,964          
Exercise of share options 861 $ 2 859        
Issue of restricted share units (in shares)   89,799          
Issue of restricted share units 6 $ 6          
Non-cash stock compensation expense 6,035   6,035        
Share issuance costs (3)   (3)        
Share repurchase program (in shares)   (1,235,218)          
Share repurchase program (175,000) $ (82)   82   (175,000)  
Share repurchase costs (140)         (140)  
Other comprehensive income, net of tax (23,136)       (23,136)    
Noncontrolling interest redemption adjustment (4,522)         (4,522) $ 4,522
Ending balance (in shares) at Mar. 31, 2020   52,508,751          
Ending balance at Mar. 31, 2020 1,513,852 $ 4,561 584,852 1,134 (98,955) 1,022,260  
Beginning balance at Dec. 31, 2019             39,510
Increase (Decrease) in Temporary Equity [Roll Forward]              
Net income             633
Noncontrolling interest redemption adjustment (4,522)         (4,522) 4,522
Exercise of call option on noncontrolling interest             (44,665)
Ending balance at Mar. 31, 2020             0
Beginning balance (in shares) at Dec. 31, 2019   53,622,206          
Beginning balance at Dec. 31, 2019 1,618,055 $ 4,635 577,961 1,052 (75,819) 1,110,226  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 231,097            
Ending balance (in shares) at Sep. 30, 2020   52,775,243          
Ending balance at Sep. 30, 2020 1,711,116 $ 4,579 610,240 1,134 (66,498) 1,161,661  
Beginning balance at Dec. 31, 2019             39,510
Ending balance at Sep. 30, 2020             0
Beginning balance (in shares) at Dec. 31, 2019   53,622,206          
Beginning balance at Dec. 31, 2019 $ 1,618,055 $ 4,635 577,961 1,052 (75,819) 1,110,226  
Ending balance (in shares) at Dec. 31, 2020 52,788,093 52,788,093          
Ending balance at Dec. 31, 2020 $ 1,850,236 $ 4,580 617,104 1,134 (35,477) 1,262,895  
Beginning balance at Dec. 31, 2019             39,510
Beginning balance (in shares) at Mar. 31, 2020   52,508,751          
Beginning balance at Mar. 31, 2020 1,513,852 $ 4,561 584,852 1,134 (98,955) 1,022,260  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 47,760         47,760  
Exercise of share options (in shares)   8,235          
Exercise of share options 587 $ 1 586        
Issue of restricted share units (in shares)   112,081          
Issue of restricted share units 7 $ 7          
Non-cash stock compensation expense 7,065   7,065        
Share issuance costs (3)   (3)        
Other comprehensive income, net of tax 9,215       9,215    
Ending balance (in shares) at Jun. 30, 2020   52,629,067          
Ending balance at Jun. 30, 2020 1,578,483 $ 4,569 592,500 1,134 (89,740) 1,070,020  
Beginning balance at Mar. 31, 2020             0
Ending balance at Jun. 30, 2020             0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 91,641         91,641  
Exercise of share options (in shares)   140,945          
Exercise of share options 10,887 $ 9 10,878        
Issue of restricted share units (in shares)   5,231          
Issue of restricted share units 1 $ 1          
Non-cash stock compensation expense 6,866   6,866        
Share issuance costs (4)   (4)        
Other comprehensive income, net of tax 23,242       23,242    
Ending balance (in shares) at Sep. 30, 2020   52,775,243          
Ending balance at Sep. 30, 2020 $ 1,711,116 $ 4,579 610,240 1,134 (66,498) 1,161,661  
Ending balance at Sep. 30, 2020             $ 0
Beginning balance (in shares) at Dec. 31, 2020 52,788,093 52,788,093          
Beginning balance at Dec. 31, 2020 $ 1,850,236 $ 4,580 617,104 1,134 (35,477) 1,262,895  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 97,122         97,122  
Exercise of share options 0            
Issue of restricted share units (in shares)   70,097          
Issue of restricted share units 5 $ 5          
Non-cash stock compensation expense 6,310   6,310        
Share issuance costs (5)   (5)        
Other comprehensive income, net of tax (19,497)       (19,497)    
Ending balance (in shares) at Mar. 31, 2021   52,858,190          
Ending balance at Mar. 31, 2021 $ 1,934,171 $ 4,585 623,409 1,134 (54,974) 1,360,017  
Beginning balance (in shares) at Dec. 31, 2020 52,788,093 52,788,093          
Beginning balance at Dec. 31, 2020 $ 1,850,236 $ 4,580 617,104 1,134 (35,477) 1,262,895  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) $ 76,717            
Ending balance (in shares) at Sep. 30, 2021 81,397,821 81,397,821          
Ending balance at Sep. 30, 2021 $ 7,968,586 $ 6,629 6,700,407 1,134 (79,196) 1,339,612  
Beginning balance (in shares) at Mar. 31, 2021   52,858,190          
Beginning balance at Mar. 31, 2021 1,934,171 $ 4,585 623,409 1,134 (54,974) 1,360,017  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 73,865         73,865  
Exercise of share options (in shares)   4,020          
Exercise of share options 170   170        
Issue of restricted share units (in shares)   95,853          
Issue of restricted share units 7 $ 7          
Non-cash stock compensation expense 8,495   8,495        
Share issuance costs (5)   (5)        
Other comprehensive income, net of tax 11,240       11,240    
Ending balance (in shares) at Jun. 30, 2021   52,958,063          
Ending balance at Jun. 30, 2021 2,027,943 $ 4,592 632,069 1,134 (43,734) 1,433,882  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (94,270)         (94,270)  
Exercise of share options (in shares)   909,723          
Exercise of share options 103,865 $ 54 103,811        
Issue of restricted share units (in shares)   157,608          
Issue of restricted share units 23 $ 23          
Issue of shares associated with a business combination (in shares)   27,372,427          
Issue of shares associated with a business combination 5,658,126 $ 1,960 5,656,166        
Replacement share-based awards issued to acquiree employees 209,399   209,399        
Non-cash stock compensation expense 99,771   99,771        
Share issuance costs (809)   (809)        
Other comprehensive income, net of tax $ (35,462)       (35,462)    
Ending balance (in shares) at Sep. 30, 2021 81,397,821 81,397,821          
Ending balance at Sep. 30, 2021 $ 7,968,586 $ 6,629 $ 6,700,407 $ 1,134 $ (79,196) $ 1,339,612